Skip to content

EFFECT OF KINESIO TAPING AND LASER THERAPY IN PATIENT WITH LYMPHEDEMA ON GIRTH MEASUREMENT

THE EFFECT OF KINESIO TAPING AND LOW LEVEL LASER THERAPY IN PATIENT WITH POST MASTECTOMY RELATED LYMPHEDEMA ON GIRTH MEASUREMENT

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06808178
Acronym
LYMPHEDEMA
Enrollment
90
Registered
2025-02-05
Start date
2025-02-01
Completion date
2025-09-01
Last updated
2026-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer Stage II, Lymphedema

Keywords

laser taping

Brief summary

find out the difference in the effect of kinesio taping and low level laser therapy on 66 patients with post mastectomy lymphedema as regards the following outcomes: 1.girth measurement between the upper limbs 2.) SPADI 3) hand grip strength 4)the quality of life by cancer specific questionnaire.

Detailed description

60 females with BCRL will be recruited in this study for 4 weeks , their age ranged from 400 to 55 years old with stege 1,2 lymphedema and randomly divided into 3 equal groups: 2) study group (A) include 20 females with unilateral BCRL will receive kinesio taping plus manual lymphatic drainage , exercise and advices 3) study group (B) include 20 females with unilateral BCRL will receive low level laser therapy plus manual lymphatic drainage , exercise and advices 4) study group (C) include 20 females with unilateral BCRL will receive kinesio taping plus low level laser therapy and manual lymphatic drainage , exercise and advices regards the following outcomes: 1.girth measurement between the upper limbs 2.) SPADI 3) hand grip strength 4)the quality of life by cancer specific questionnaire.

Interventions

OTHERkinesio taping

* the material used is 100%acrylic,latex free and heat activated with 10-15% stretch. * It is made of 100% cotton to allow quickening of the drying process. * Ability to stretch to 120-140% of its original length * Recoil back to the anchor that is applied without stretch * Heat-activated adhesive * Hypoallergenic dyes that make the tape safe for most users * Latex-free * Drying time after being wet is about 5-10 minutes * Can be worn for several days

DEVICELow Level Laser Therapy

The device has the following treatment parametes : * Maximum average power \> 500 milli watts * Wave length combined (904-808) nm * Maximum repition rate (1-2000) Hz * Energy density : 4:6 J per cm per session

Sponsors

Beni-Suef University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

60 females with BCRL will be recruited in this study for 4 weeks , their age ranged from 400 to 55 years old with stege 1,2 lymphedema and randomly divided into 3 equal groups: 2) study group (A) include 20 females with unilateral BCRL will receive kinesio taping plus manual lymphatic drainage , exercise and advices 3) study group (B) include 20 females with unilateral BCRL will receive low level laser therapy plus manual lymphatic drainage , exercise and advices 4) study group (C) include 20 females with unilateral BCRL will receive kinesio taping plus low level laser therapy and manual lymphatic drainage , exercise and advices

Eligibility

Sex/Gender
FEMALE
Age
40 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* persistence of lymphedema following mastectomy or breast conservative surgery for at least 3 months * minimum volume difference of 200 mL or an average difference in arm circumference of 2 cm or 10% between healthy and affected limbs. * Femal with unilateral lymphedema from 40 to 55 years old

Exclusion criteria

* • Any disease lead to swelling * Medication especially diuretics * allergy * infection * pregnancy * heart band kidney disease * bilateral lymphedema * skin disease * chronic inflammatory disease

Design outcomes

Primary

MeasureTime frameDescription
girth measurment4 weeksMeasurement of arm circumference is the most commonly used technique for identifying lymphedema and is reliable for both surgical and nonsurgical upper limbs It is measured using a tape with the patient in prone lying position, with elbows straight and arms relaxed at the sides. It was measured starting with 3 cm on the ulnar styloid process and proceeding with 45 cm proximal, and additionally at the metacarpal bones and mid-hand. The tape measure was put around the limb to prevent it from slacking and to ensure that there was no space in the tissue. The total circumference of the sound limb was ascertained similarly. The difference between the 2 measurements was identified using "circumference difference."
handgrip strength4 weeksevaluated using a dynamometer ,The grip strength was measured with the patient in a standing position with adducted shoulder, elbow flexed at 90°, and forearm in mid position. The patient was instructed to do 3 trials with 15 seconds rest in between each, and the highest reading was reported

Secondary

MeasureTime frameDescription
shoulder pain and disability index4 weekswas used to assess shoulder pain and disability. It incorporates 13 items assessing 2 domains: 5 items assess pain and 8 items evaluate disability.
quality of life questionnaire4 weekswas assessed by cancer-specific questionnaire (EORTC QLQ-C30). It is composed of 30 questions, including functional scores (physical, social, emotional, and cognitive aspects). The functional scores ranged between 0 and 100, and higher scores indicated better condition. This questionnaire also included symptoms score (pain, dyspnea, fatigue, insomnia, nausea, loss of appetite, and financial problems). The symptom scores ranged from 100 to 0, and lower scores indicated better condition

Countries

Egypt

Contacts

PRINCIPAL_INVESTIGATORMERIT MAGDY ZAKI, physiotherapist

beni suif university

STUDY_CHAIRSHERIN HASSAN MEHANI, Professor of Physical therapy

beni suif university

STUDY_DIRECTORMAHMOUD AWD ELKHOLY, Lecturer of physical therapy

beni suif university

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 13, 2026